Maven Securities’s Idexx Laboratories IDXX Stock Holding History

Maven Securities’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,500	Closed	-$1.34M	–	632
2025 Q2	$1.34M	Buy	+2,500	New	+$1.2M	0.03%	380
2024 Q4	–	Sell	-2,100	Closed	-$1.06M	–	914
2024 Q3	$1.06M	Sell	2,100 -2,800	-57%	-$1.36M	0.02%	479
2024 Q2	$2.39M	Buy	+4,900	New	+$2.46M	0.05%	331
2023 Q4	–	Sell	-3,100	Closed	-$1.36M	–	1049
2023 Q3	$1.36M	Buy	+3,100	New	+$1.55M	0.02%	517
2023 Q2	–	Sell	-400	Closed	-$200K	–	954
2023 Q1	$200K	Buy	+400	New	+$191K	﹤0.01%	883
2022 Q2	–	Sell	-100	Closed	-$55K	–	994
2022 Q1	$55K	Buy	+100	New	+$52.6K	﹤0.01%	902
2021 Q4	–	Sell	-400	Closed	-$249K	–	979
2021 Q3	$249K	Buy	+400	New	+$269K	0.01%	899

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Maven Securities's IDXX Position: Q4 2024 in Review

Maven Securities sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 748 shares — an estimated $378K sold.

Maven Securities first reported a position in IDXX in Q1 2020 and held it in 8 quarters. The position peaked at $515K in Q2 2024. 1,123 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

Maven Securities reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
Maven Securities sold 748 Idexx Laboratories shares in Q4 2024, an estimated $378K.
Maven Securities first reported a position in Idexx Laboratories in Q1 2020 and held it in 8 quarters.
Maven Securities's Idexx Laboratories position peaked at $515K in Q2 2024.
1,123 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.